Exane Derivatives Bio Techne Corp Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
A detailed history of Exane Derivatives transactions in Bio Techne Corp stock. As of the latest transaction made, Exane Derivatives holds 407 shares of TECH stock, worth $30,394. This represents 0.09% of its overall portfolio holdings.
Number of Shares
407
Previous 407
-0.0%
Holding current value
$30,394
Previous $176,000
19.89%
% of portfolio
0.09%
Previous 0.05%
Shares
1 transactions
Others Institutions Holding TECH
# of Institutions
604Shares Held
153MCall Options Held
171KPut Options Held
56.9K-
Vanguard Group Inc Valley Forge, PA18.2MShares$1.36 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY15MShares$1.12 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD8.53MShares$637 Million0.07% of portfolio
-
State Street Corp Boston, MA6.3MShares$471 Million0.02% of portfolio
-
Bamco Inc New York, NY4.78MShares$357 Million1.0% of portfolio
About BIO-TECHNE Corp
- Ticker TECH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,222,600
- Market Cap $2.93B
- Description
- Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...